生物科技公司Twist Bioscience（TWST）周二盘中股价大跌5.20%，引发投资者关注。截至报道时，该公司股价仍在持续下滑。
消息面上，摩根大通分析师今日将Twist Bioscience的目标价从40美元下调至33美元，这一举动似乎直接触发了投资者的抛售情绪。华尔街分析师对公司前景的看法转向谨慎，通常会对股价产生显著影响。
Twist Bioscience是一家专注于DNA合成技术的生物科技公司。尽管公司在合成生物学领域占据领先地位，但近期可能面临一些挑战，导致分析师下调其估值预期。投资者应密切关注公司未来的财务表现和行业发展动态，以评估这一股价调整是短期波动还是长期趋势的开始。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.